Ratings by Credit Suisse (Katie Tryhane)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/10/2021 | Danaher | DHR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/17/2021 | Sophia Genetics SA | SOPH | New Coverage | Outperform (N/A) |
18.00 (8.09) |
-55.06% | Details | |
| 8/13/2021 | IDEXX Laboratories | IDXX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2021 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2021 | Fulgent Genetics | FLGT | Maintain | Underperform (N/A) |
|
Details | ||
| 8/10/2021 | Syneos | SYNH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2021 | Zoetis Inc. | ZTS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2021 | Zoetis Inc. | ZTS | New Coverage | Outperform (N/A) |
204.10 (75.81) |
-62.86% | Details | |
| 8/5/2021 | Thermo Fisher Scientific | TMO | New Coverage | Outperform (N/A) |
536.99 (613.78) |
14.3% | Details | |
| 8/5/2021 | Syneos | SYNH | New Coverage | Outperform (N/A) |
88.10 (42.98) |
-51.21% | Details | |
| 8/5/2021 | PPD Inc. | PPD | New Coverage | Neutral (N/A) |
46.32 (47.30) |
2.12% | Details | |
| 8/5/2021 | Phibro Animal Health Corp. | PAHC | New Coverage | Neutral (N/A) |
24.56 (38.25) |
55.74% | Details | |
| 8/5/2021 | PetMed Express | PETS | New Coverage | Underperform (N/A) |
30.00 (1.81) |
-93.97% | Details | |
| 8/5/2021 | Ortho Clinical Diagnostics | OCDX | New Coverage | Outperform (N/A) |
21.62 (17.63) |
-18.46% | Details | |
| 8/5/2021 | Medpace | MEDP | New Coverage | Outperform (N/A) |
176.64 (591.29) |
234.74% | Details | |
| 8/5/2021 | Maravai LifeScience Holdings Inc. | MRVI | New Coverage | Outperform (N/A) |
47.72 (7.32) |
-84.66% | Details | |
| 8/5/2021 | IQVIA Holdings | IQV | New Coverage | Outperform (N/A) |
249.98 (267.77) |
7.12% | Details | |
| 8/5/2021 | IDEXX Laboratories | IDXX | New Coverage | Outperform (N/A) |
695.67 (535.38) |
-23.04% | Details | |
| 8/5/2021 | ICON plc | ICLR | New Coverage | Outperform (N/A) |
244.08 (164.85) |
-32.46% | Details | |
| 8/5/2021 | Fulgent Genetics | FLGT | New Coverage | Underperform (N/A) |
100.46 (19.73) |
-80.36% | Details | |
| 8/5/2021 | Elanco Animal Health | ELAN | New Coverage | Outperform (N/A) |
36.72 (24.50) |
-33.28% | Details | |
| 8/5/2021 | Danaher | DHR | New Coverage | Outperform (N/A) |
302.33 (207.66) |
-31.31% | Details | |
| 8/5/2021 | Covetrus | CVET | New Coverage | Neutral (N/A) |
24.69 (20.99) |
-14.99% | Details | |
| 8/5/2021 | Chewy Inc. | CHWY | New Coverage | Outperform (N/A) |
86.75 (23.66) |
-72.73% | Details | |
| 8/5/2021 | Charles River Labs | CRL | New Coverage | Neutral (N/A) |
411.24 (288.50) |
-29.85% | Details | |
| 8/5/2021 | Certara Inc. | CERT | New Coverage | Neutral (N/A) |
26.31 (7.94) |
-69.82% | Details | |
| 8/5/2021 | Centogene NV | CNTG | New Coverage | Outperform (N/A) |
11.39 (0.33) |
-97.1% | Details | |
| 8/5/2021 | Avantor Inc. | AVTR | New Coverage | Outperform (N/A) |
37.80 (14.97) |
-60.4% | Details |
